ResMed To Add To Software Offerings With $750M MatrixCare Acquisition
Xconomy
NOVEMBER 5, 2018
The purchase price is 25 times MatrixCare’s pro forma 2018 earnings of about $30 million (without taking into account interest, taxes, depreciation or amortization) on anticipated net revenue of about $122 million. ResMed, which brought in net income of $315.6 million on revenues of $2.3
89 
Let's personalize your content